AlphaStocks
2.9
Avoid

HEALTHSTREAM INC (HSTM)

Health Care / Health Care Technology

S&P SmallCap 600

$20.42

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

#1017out of 1127 in Health Care

Is HEALTHSTREAM INC a Good Investment in 2026?

HEALTHSTREAM INC (HSTM) scores 2.9 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates HEALTHSTREAM INC as Attractive (5/9). However, the Graham model rates it Caution — 67% above fair value. HEALTHSTREAM INC currently trades above its estimated fair value of $14, suggesting limited upside at current prices. HEALTHSTREAM INC ranks #1017 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E33.6ROE5.2Market Cap615.5MDiv Yield0.6

Estimated Fair Value

$13.9746% above

Trading above estimated fair value. Eps growth of -7% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

67% above fair value

Lynch

Attractive

High PEG — growth premium · Slow Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is HEALTHSTREAM INC (HSTM) a good investment?
Based on AlphaStocks' composite analysis, HEALTHSTREAM INC (HSTM) scores 2.9 out of 10, earning a Avoid rating. This score is below average, suggesting caution. Trading above estimated fair value. Eps growth of -7% may not justify the premium.
What is HEALTHSTREAM INC's Piotroski F-Score?
HEALTHSTREAM INC's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HSTM overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $14, HSTM appears overvalued. The stock currently trades 46% above its estimated fair value. Trading above estimated fair value. Eps growth of -7% may not justify the premium.
How does HSTM compare to other Health Care stocks?
HEALTHSTREAM INC ranks #1017 out of 1127 stocks in the Health Care sector, placing it in the top 90% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about HSTM?
AlphaStocks evaluates HSTM using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Attractive. These models are combined into a single composite score of 2.9/10.

Similar Stocks

PARRFTIAZN

Compare HSTM with

HSTM vs PARRHSTM vs FTIHSTM vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer